Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BIRC6 encodes a protein with a BIR (baculoviral inhibition of apoptosis protein repeat) domain and a UBCc (ubiquitin-conjugating enzyme E2, catalytic) domain. Additionally we are shipping BIRC6 Kits (9) and and many more products for this protein.
Showing 10 out of 68 products:
Human Polyclonal BIRC6 Primary Antibody for ICC, IF - ABIN4284734
Dong, Lin, Low, Vucic, English, Yee, Murray, Lam, Ling, Lam, Gout, Wang: Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013
Show all 4 Pubmed References
Dog (Canine) Monoclonal BIRC6 Primary Antibody for IF, WB - ABIN968408
Hauser, Bardroff, Pyrowolakis, Jentsch: A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. in The Journal of cell biology 1998
Human Polyclonal BIRC6 Primary Antibody for ICC, IF - ABIN152603
Aharinejad, Andrukhova, Lucas, Zuckermann, Wieselthaler, Wolner, Grimm: Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon. in The Annals of thoracic surgery 2008
Cow (Bovine) Polyclonal BIRC6 Primary Antibody for ELISA, ICC - ABIN4284735
Lopergolo, Pennati, Gandellini, Orlotti, Poma, Daidone, Folini, Zaffaroni: Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. in British journal of cancer 2009
Since specific expression of BRUCE protein was revealed in majority of gastric carcinoma tissues, BRUCE protein may be a useful therapeutic target for cancer therapy.
BIRC6 targeting inhibited the growth of enzalutamide-resistant castration-resistant prostate cancer models and may represent a new option for clinical treatment of advanced, enzalutamide-resistant prostate cancer
AVEN (show AVEN Antibodies) and BIRC6 are inhibited by combination therapy of miR (show MLXIP Antibodies)-30e and proanthocyanidin in glioblastoma stem cells
Apollon expression is associated with the biological characteristics of esophageal squamous cell carcinoma (ESCC), and may be a valuable prognostic factor and a novel chemotherapeutic target for ESCC treatment.
Apollon role in the multidrug resistance of human chronic myelogenous leukemia cells
Apollon gene silencing can induce apoptosis and growth impairment in HeLa cells. In this regard, apollon can be considered a candidate therapeutic target in HeLa cells as a positive human papillomavirus cancer cell line.
BRUCE protein was detected in 82% of tumors and tumor progression stage and invasion depth correlated significantly with BRUCE protein expression
Results show that in addition to the scaffolding function in complex formation, BRUCE has an E3 ligase function to promote BRIT1 (show MCPH1 Antibodies) deubiquitination by USP8 (show USP8 Antibodies) leading to accumulation of BRIT1 (show MCPH1 Antibodies) at DNA double-strand break.
BIRC6 overexpression is a predictor of poor prognosis in colorectal cancer and could be a potential target for colorectal cancer therapy.
The study demonstrates that the T allele of the rs2754511 in the BIRC6 gene plays a protective role in pseudoexfoliative glaucoma patients of the Pakistani population.
The results of this study reveal the importance of BIRC6 expression for embryo survival during bovine preimplantation embryo development.
Humanin signaling pathway via htHNR/JAKs/STAT3 (show STAT3 Antibodies) increased the expression levels of mRNA and protein of Apollon/Bruce, an unusual member of the inhibitors of apoptosis proteins
BRUCE acts as a scaffold, bridging the ubiquitin-specific peptidase 8 (USP8 (show USP8 Antibodies)) and BRIT1 (show MCPH1 Antibodies) in a complex to coordinate USP8 (show USP8 Antibodies)-catalyzed deubiquitination of BRIT1 (show MCPH1 Antibodies).
BRUCE protects cells against apoptosis and functions as an inhibitor of apoptosis.
BRUCE is broadly expressed in embryonic, extraembryonic, and adult mouse tissues, this bifunctional protein might play a unique role in normal trophoblast differentiation and embryonic survival
p53 (show TP53 Antibodies) is a downstream effector of Bruce, and, in response to loss of Bruce function, p53 (show TP53 Antibodies) activates Pidd (show PIDD Antibodies)/caspase-2 (show CASP2 Antibodies) and Bax (show BAX Antibodies)/Bak (show BAK1 Antibodies), leading to mitochondrial apoptosis
Birc6 plays a role in cell division
These results establish a previously unrecognized link between NFAT (show NFATC1 Antibodies) signaling and regulation of IAP (show ALPI Antibodies) expression and are the first to identify a signaling pathway that increases BRUCE expression.
This gene encodes a protein with a BIR (baculoviral inhibition of apoptosis protein repeat) domain and a UBCc (ubiquitin-conjugating enzyme E2, catalytic) domain. This protein inhibits apoptosis by facilitating the degradation of apoptotic proteins by ubiquitination.
BIR repeat-containing ubiquitin-conjugating enzyme
, baculoviral IAP repeat-containing 6
, baculoviral IAP repeat-containing protein 6
, ubiquitin-conjugating BIR domain enzyme apollon
, ubiquitin-conjugating BIR-domain enzyme apollon
, baculoviral IAP repeat-containing 6 (apollon)
, baculovirus inhibitor of apoptosis repeat containing ubiquitin-conjugating enzyme
, baculovirus inhibitor of apoptosis repeat containing ubiquitin-conjugating enzyme; accccbaculoviral IAP repeat-containing 6